Rockwell Medical, Inc. (RMTI)

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2025 on Thursday, March 26, 2026.

Rockwell Medical (RMTI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical has been certified as a Great Place to Work for the fourth year in a row.

Rockwell Medical (NASDAQ: RMTI - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation. Risk and Volatility Rockwell Medical has a beta

Rockwell Medical (RMTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Rockwell Medical (RMTI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--$RMTI announced preliminary unaudited financial results for the three months and twelve months ended December 31, 2025.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is a viable alternative supplier in the western U.S., serving customers with a reliable supply chain and high-quality products.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical extends its product purchase agreement with one of the largest dialysis providers in the United States through December 31, 2026.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Joe Dawson is a seasoned executive who has extensive operational experience and a strong network in the renal care space.

Rockwell Medical, Inc. ( RMTI ) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Company Participants Heather Hunter - Senior VP & COO Mark Strobeck - President, CEO & Director Jesse Neri - Senior VP & CFO Conference Call Participants Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Nicholas Sherwood - Maxim Group LLC, Research Division Anthony Vendetti - Maxim Group LLC, Research Division Presentation Operator Good morning, and welcome to Rockwell Medical's Third Quarter 2025 Results Conference Call and Webcast.

Rockwell Medical (RMTI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.05 per share a year ago.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical achieved profitability on an Adjusted EBITDA basis for the third quarter 2025.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Mr. Brown has built a distinguished career leading complex manufacturing and supply chain organizations.